Description
This product utilizes regulatory B cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone W0R72). We employs the Adenovirus (T7-Cy5-ER-EcoRI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Balancing feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD22
Clone
W0R72
Species Reactivity
Human
Cell Source
Regulatory B cells
Sensor Gene
Cy5
Promoter
T7
Effector Gene
ER
Insertion Sites
EcoRI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
Adenovirus
Transformation Accuracy
0.99
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.